Nitric Oxide–Producing Myeloid-Derived Suppressor Cells Inhibit Vascular E-Selectin Expression in Human Squamous Cell Carcinomas
Open Access
- 1 November 2012
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 132 (11) , 2642-2651
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13Cancer Immunology, Immunotherapy, 2011
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironmentJournal of Experimental Medicine, 2010
- Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination modelJournal of Neuroimmunology, 2010
- Skin-Resident T Cells: The Ups and Downs of On Site ImmunityJournal of Investigative Dermatology, 2010
- Imiquimod Enhances IFN-γ Production and Effector Function of T Cells Infiltrating Human Squamous Cell Carcinomas of the SkinJournal of Investigative Dermatology, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsJournal of Experimental Medicine, 2008
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patientsBritish Journal of Dermatology, 2007
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004